You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for New Drug Application (NDA): 019271


✉ Email this page to a colleague

« Back to Dashboard


NDA 019271 describes CHROMIC CHLORIDE, which is a drug marketed by Abraxis Pharm and Hospira and is included in two NDAs. Additional details are available on the CHROMIC CHLORIDE profile page.

The generic ingredient in CHROMIC CHLORIDE is chromic chloride. Two suppliers are listed for this compound. Additional details are available on the chromic chloride profile page.
Summary for 019271
Tradename:CHROMIC CHLORIDE
Applicant:Abraxis Pharm
Ingredient:chromic chloride
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 0.004MG CHROMIUM/ML
Approval Date:May 5, 1987TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.